Conference Coverage

VIDEO: Evidence backs marijuana for multiple sclerosis


 

EXPERT ANALYSIS FROM THE CMSC/ACTRIMS ANNUAL MEETING

DALLAS – It might come as a surprise to learn how many good studies there are to support marijuana for multiple sclerosis, especially for subjective symptoms. The data are summarized in recent MS complementary and alternative medicine guidelines from the American Academy of Neurology.

But most of those studies were done using standardized products not available in the United States, which means that U.S. providers have to give advice in a country in which marijuana types and products vary considerably. It comes down to a case-by-case approach, Dr. Allen C. Bowling of the Colorado Neurological Institute, Englewood, explained in a video interview at a meeting of the Consortium of Multiple Sclerosis Centers and the Americas Committee for Treatment and Research in Multiple Sclerosis.

The video associated with this article is no longer available on this site. Please view all of our videos on the MDedge YouTube channel.

aotto@frontlinemedcom.com

Recommended Reading

Spinal fluid may help flesh out natalizumab-associated PML diagnosis
MDedge Internal Medicine
VIDEO: New meds, remyelination therapies move ahead in multiple sclerosis
MDedge Internal Medicine
Proposed neuromyelitis optica diagnostic criteria reflect new disease understanding
MDedge Internal Medicine
Dalfampridine’s effects on walking ability in MS extend to 24 weeks
MDedge Internal Medicine
Lesion length, number correspond to neuromyelitis optica Dx
MDedge Internal Medicine
Alemtuzumab found to reduce brain lesions, volume loss
MDedge Internal Medicine
iPad app could change how MS is measured, treated
MDedge Internal Medicine
VIDEO: New MS database could change practice
MDedge Internal Medicine
Improved outcomes seen with raising vitamin D levels in early MS
MDedge Internal Medicine
Exercise is generally safe for MS patients
MDedge Internal Medicine

Related Articles